Literature DB >> 22467547

Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus.

Elizabeth C Verna1, Rosa Valadao, Erica Farrand, Elsa M Pichardo, Jennifer C Lai, Norah A Terrault, Robert S Brown.   

Abstract

The ethnicity and socioeconomic status of the host may affect the progression of hepatitis C virus (HCV). We aimed to compare survival and fibrosis progression in Hispanic white (HW) and non-Hispanic white (NHW) recipients of liver transplantation (LT) with HCV. All HW and NHW patients with HCV who underwent transplantation between January 2000 and December 2007 at 2 centers were retrospectively assessed. The primary outcomes were the time to death, death or graft loss due to HCV, and significant fibrosis [at least stage 2 of 4]. Five hundred eleven patients were studied (159 HW patients and 352 NHW patients), and the baseline demographics were similar for the 2 groups. NHW patients were more likely to be male, to have attended college, and to have private insurance, and they had a higher median household income (MHI). The unadjusted rates of survival (log-rank P = 0.93), death or graft loss due to HCV (P = 0.89), and significant fibrosis (P = 0.95) were similar between groups. In a multivariate analysis controlling for center, age [hazard ratio (HR) per 10 years = 1.43, P = 0.01], donor age (HR per 10 years = 1.25, P < 0.001), and rejection (HR = 1.47, P = 0.048) predicted death, whereas HW ethnicity (HR = 1.06, P = 0.77) was not significant. Independent predictors of significant fibrosis were HW ethnicity (HR = 2.42, P = 0.046), MHI (HR per $10,000 = 1.11, P = 0.01), donor age (HR per 10 years = 1.13, P = 0.02), cold ischemia time (HR = 1.06, P = 0.03), and the interaction between ethnicity and MHI (HR = 0.82, P = 0.03). In conclusion, there is no difference in post-LT survival or graft loss due to HCV between HW patients and NHW patients. Socioeconomic factors may influence disease severity; this is suggested by our findings of more significant fibrosis in HW patients with a low MHI.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22467547      PMCID: PMC3674870          DOI: 10.1002/lt.23376

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  36 in total

1.  Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C.

Authors:  Varun Saxena; Jennifer C Lai; Jacqueline G O'Leary; Elizabeth C Verna; Robert S Brown; R Todd Stravitz; James F Trotter; Kartik Krishnan; Norah A Terrault
Journal:  Liver Transpl       Date:  2012-05       Impact factor: 5.799

2.  More advanced hepatic fibrosis in hispanics with chronic hepatitis C infection: role of patient demographics, hepatic necroinflammation, and steatosis.

Authors:  Sumita Verma; Maurizio Bonacini; Sugantha Govindarajan; Gary Kanel; Karen L Lindsay; Allan Redeker
Journal:  Am J Gastroenterol       Date:  2006-06-22       Impact factor: 10.864

3.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

4.  Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes.

Authors:  Ramsey C Cheung; Sue Currie; Hui Shen; Samuel B Ho; Edmund J Bini; Bhupinderjit S Anand; Norbert Bräu; Teresa L Wright
Journal:  Am J Gastroenterol       Date:  2005-10       Impact factor: 10.864

5.  UCLA liver transplantation: analysis of immunological factors affecting outcome.

Authors:  S Dawson; D K Imagawa; C Johnson; M Cecka; P I Terasaki; C R Shackleton; R W Busuttil
Journal:  Artif Organs       Date:  1996-10       Impact factor: 3.094

Review 6.  Diabetes in the Hispanic or Latino population: genes, environment, culture, and more.

Authors:  A Enrique Caballero
Journal:  Curr Diab Rep       Date:  2005-06       Impact factor: 4.810

7.  Adolescent non-adherence: prevalence and consequences in liver transplant recipients.

Authors:  R K Berquist; W E Berquist; C O Esquivel; K L Cox; K I Wayman; I F Litt
Journal:  Pediatr Transplant       Date:  2006-05

8.  Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group.

Authors:  J F Neylan
Journal:  Transplantation       Date:  1998-02-27       Impact factor: 4.939

9.  Payer status, but not race, affects the cost of liver transplantation.

Authors:  M W Russo; R S Sandler; L Mandelkehr; J H Fair; M W Johnson; R S Brown
Journal:  Liver Transpl Surg       Date:  1998-09

10.  The association of HLA-DR13 with lower graft survival rates in hepatitis B and primary sclerosing cholangitis Caucasian patients receiving a liver transplant.

Authors:  Yasuro Futagawa; Kayo Waki; Junchao Cai
Journal:  Liver Transpl       Date:  2006-04       Impact factor: 5.799

View more
  6 in total

1.  Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.

Authors:  Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader; Mohamed Hassan
Journal:  World J Hepatol       Date:  2012-12-27

2.  Prevalence of cirrhosis in hepatitis C patients in the Chronic Hepatitis Cohort Study (CHeCS): a retrospective and prospective observational study.

Authors:  Stuart C Gordon; Lois E Lamerato; Loralee B Rupp; Scott D Holmberg; Anne C Moorman; Philip R Spradling; Eyasu Teshale; Fujie Xu; Joseph A Boscarino; Vinutha Vijayadeva; Mark A Schmidt; Nancy Oja-Tebbe; Mei Lu
Journal:  Am J Gastroenterol       Date:  2015-07-28       Impact factor: 10.864

3.  A moral dilemma argument against clinical trials of incentives for kidney donation.

Authors:  G V Ramesh Prasad
Journal:  Transplant Res       Date:  2015-07-22

Review 4.  Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review.

Authors:  Oscar Mitchell; Ahmet Gurakar
Journal:  J Clin Transl Hepatol       Date:  2015-06-15

5.  Socioeconomic status in HCV infected patients - risk and prognosis.

Authors:  Lars Haukali Omland; Merete Osler; Peter Jepsen; Henrik Krarup; Nina Weis; Peer Brehm Christensen; Casper Roed; Henrik Toft Sørensen; Niels Obel
Journal:  Clin Epidemiol       Date:  2013-05-31       Impact factor: 4.790

Review 6.  Challenging hepatitis C-infected liver transplant patients.

Authors:  Madeleine Oliver; Christopher Chiodo Ortiz; Jorge Ortiz
Journal:  Hepat Med       Date:  2016-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.